---  
layout: startup_page  
title: "Merida Biosciences"  
id: "meridabio.com"  
permalink: "/meridabiosciencesmeridabio.com04082025/"  
website: "https://www.meridabio.com"  
funding_round: "Series A"  
funding_amount: "$121M"  
investors: "Bain Capital Life Sciences, BVF Partners, Third Rock Ventures, GV, Perceptive Xontogeny Venture Funds (PXV Funds)"  
about: "Merida Biosciences is a biotechnology company developing a new class of precision therapeutics to eliminate pathogenic antibody drivers in autoimmune and allergic diseases. Their novel platform targets specific antibodies, offering durable depletion without broad immunosuppression. The company has programs targeting Gravesâ€™ disease, allergy, and primary membranous nephropathy."  
markets: "Biotechnology, Therapeutics, Autoimmune Diseases, Allergic Diseases"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/merida-biosciences"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/merida-biosciences"  
pitchbook: "https://pitchbook.com/profiles/company/772636-78"  

date_display: "08-Apr-2025"  
date: "2025-04-08"

# SEO Optimization  
meta_title: "Merida Biosciences - Series A Funding ($121M)"  
meta_description: "Merida Biosciences, Merida Biosciences is a biotechnology company developing a new class of precision therapeutics to eliminate pathogenic antibody drivers in autoimmune ..."  
meta_keywords: "Merida Biosciences, Biotechnology, Therapeutics, Autoimmune Diseases, Allergic Diseases, Series A funding"  
canonical_url: "https://startup.projectstartups.com/meridabiosciencesmeridabio.com04082025/"  
---